Research has implications for human health, cancer treatment In a new review paper, Carlo Maley and Arizona State University colleagues describe cell-in-cell phenomena in which one cell engulfs and sometimes consumes another. The study…
Regular use of fish oil supplements might increase, rather than lessen, the risk of first time heart disease and stroke among those in good cardiovascular health, but may slow progression of existing…
Scientists have used breast cancer cells’ weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumours. The research, published today in Clinical Cancer Research by a team from…
A program for clinic systems created by researchers at UTHealth Houston called the Adolescent Vaccination Program (AVP) has proven to be effective at increasing human papillomavirus (HPV) vaccination rates among adolescents according to a…
When it comes to skin cancer, most people think of warnings about sunburn and tanning beds. Thoughts of “cancer genes” or inherited risks are reserved for diseases like breast cancer or colon…
Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evidence-based weight-management treatment, and led to more weight lost in…
Alcohol Use Disorder Can Be Treated with an Array of Medications – but Few People Have Heard of Them
More than 29.5 million Americans ages 12 and up had alcohol use disorder – the medical term for the disease commonly known as alcoholism – in 2022, when the most recent national…
Rutgers researchers, aided by international collaborators, have tracked the devastation war has made on Ukraine’s hospital system. Hundreds of hospitals in Ukraine have been forced to close or operate at a reduced…
A significant link between the use of electronic cigarettes and earlier age of asthma onset in U.S. adults was reported by UTHealth Houston researchers May 17, 2024 in the Journal of the American…
Results from this first use of the drug for this condition—by a team led by researchers from Massachusetts General Hospital—warrants testing the drug in a clinical trial Immune thrombotic thrombocytopenic purpura, a…